Free tool
FAERS Monitor: Pokonza
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 208019 or its brand name (Pokonza, Potassium Chloride). Reports on generic versions are filed under their own applications.
Reports
93,855
Serious
69,878
74% of reports
Hospitalization
43,163
Death reported
13,688
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- diarrhoea6,883
- dyspnoea6,840
- nausea6,627
- fatigue6,413
- death4,665
- pneumonia4,544
- headache4,281
- vomiting4,216
- asthenia4,206
- off label use4,119
- dizziness4,051
- pain3,918
- fall3,687
- drug ineffective3,641
- anaemia3,172
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 901 |
| 2005 | 1,824 |
| 2006 | 1,348 |
| 2007 | 1,683 |
| 2008 | 2,435 |
| 2009 | 2,665 |
| 2010 | 2,185 |
| 2011 | 2,587 |
| 2012 | 3,568 |
| 2013 | 2,074 |
| 2014 | 2,486 |
| 2015 | 3,933 |
| 2016 | 4,707 |
| 2017 | 4,800 |
| 2018 | 5,794 |
| 2019 | 5,661 |
| 2020 | 5,671 |
| 2021 | 6,017 |
| 2022 | 6,667 |
| 2023 | 6,693 |
| 2024 | 7,494 |
| 2025 | 7,576 |
| 2026 | 5,080 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,960,304 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| anaemiaSignal | 3,172 | 3.8 | 3.6 | 6,413 |
| pneumoniaSignal | 4,544 | 3.2 | 3.1 | 6,781 |
| dyspnoeaSignal | 6,840 | 2.7 | 2.7 | 7,603 |
| astheniaSignal | 4,206 | 2.5 | 2.4 | 3,895 |
| fallSignal | 3,687 | 2.5 | 2.4 | 3,330 |
| diarrhoeaSignal | 6,883 | 2.4 | 2.4 | 5,762 |
| vomitingSignal | 4,216 | 2.0 | 2.0 | 2,196 |
| nausea | 6,627 | 1.9 | 1.8 | 2,831 |
| fatigue | 6,413 | 1.9 | 1.8 | 2,592 |
| dizziness | 4,051 | 1.8 | 1.8 | 1,539 |
| headache | 4,281 | 1.5 | 1.5 | 814 |
| pain | 3,918 | 1.4 | 1.4 | 522 |
| death | 4,665 | 1.2 | 1.2 | 183 |
| off label use | 4,119 | 1.1 | 1.0 | 12 |
| drug ineffective | 3,641 | 0.6 | 0.6 | 914 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.